Sample Technology Commercialization Support Portal
by Polson Enterprises
Sample Number 1
Fluorescence Cancer Detection, Biomarkers and FNA Portal
We develop Portals of the nature of the one below to assist firms developing specific technologies.
This one was developed a few years ago to support a firm developing medical devices and processes.
Their specific field of interest was in detecting cancer at an early state using fluorescence. Our Portal
provided their development team easy access to the existing knowledge in this field and in competing methods.
It also provided them quick access to new information as it became available. The version below is no longer
current and many of the links are broken. It is only provided here as an example of our ability to construct
Technology Commercialization Support Portals. We can host Portals online or supply code for posting them on
your Intranet. Depending on your needs, we can also update them as new information becomes available
and as your project begin to focus on more specific areas. Please visit our
Polson Enterprises web site for more information about our capabilities.
The example below is presented exactly as we originally supplied it.
Gary Polson
Polson Enterprises
Fluorescence Cancer Detection, Biomarkers and FNA Links
Advanced Cytometrix, Inc (Sunnyvale CA) sold to Oncotech (Irvine CA). They are working on cellular predictive changes and a vacuum canister FNA Device. Trevor Powles of the UK is a major researcher for this group. Patents:
Diagnocure of Quebec Canada is doing research in the area of immuno fluorescence and bladder cancer. Their Immuno Cyt test is currently available. Fradet is a major researcher for them.
WO 98/12564 Immunological Composition for Detection of Bladder Cancer
WO 98/12227 Recombinant Single Chain Antibodies Directed Against the GP54 Cancer Marker
U.S. 5,039,611 Monoclonal Antibodies to Superficial Papillary Bladder Tumor Cells
Cancer Imaging, British Columbia Cancer Agency / Branco Palcic working with Oncometrics Imaging Corp (Vancouver CA) and Xillix Technologies Corp (Richmond B.C. Canada). Xillix liscensed the endoscope to Olympus Optico Co. Ltd. of Tokyo. Xillix also partially owns Oncometrics Imaging.
Patents:
U.S. 5,865,754 Fluorescence imaging system and method (measure lifetime of the fluorescence)
University of Oklahoma / PrevCor / George Hemstreet working on cellular predictive changes, FNA biopsy gun with a replaceable card and automated flourescense image analysis device. Patents:
U.S. 4,982,739 Biopsy Aspirator
U.S. 5,081,999 Biopsy Aspirator (method patent)
U.S. 5,387,191 Flushing Needle
U.S. 5,669,394 Biopsy Aspirator (replaceable card)
"Universal Healthcare Almanac." by Linda L. Cherner. Hardcover - 466 pages. Silver & Cherner, Ltd.; ISBN: 0964502402 is a quarterly updated manual containing procedure statistics. I was unable to find a copy in any Oklahoma public library or at the Stillwater Medical Center library. It may contain FNA statistics. It certainly should contain statistics on the various cancer operations. It is available from Amazon.com for about $180.
A comparison of Medicare reimbursement and results for various imaging-guided breast biopsy techniques.Howisey RL, Acheson MB, Rowbotham RK, Morgan A. Am J Surg; 173(5):395-8 1997. Abstract is available on CANCERLIT